Zwarthoff EC - Search Results

1

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.

Allory Y, Beukers W, Sagrera A, Flández M, Marqués M, Márquez M, van der Keur KA, Dyrskjot L, Lurkin I, Vermeij M, Carrato A, Lloreta J, Lorente JA, Carrillo-de Santa Pau E, Masius RG, Kogevinas M, Steyerberg EW, van Tilborg AA, Abas C, Orntoft TF, Zuiverloon TC, Malats N, Zwarthoff EC, Real FX. Allory Y, et al. Among authors: zwarthoff ec. Eur Urol. 2014 Feb;65(2):360-6. doi: 10.1016/j.eururo.2013.08.052. Epub 2013 Sep 7. Eur Urol. 2014. PMID: 24018021 Free article.

2

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.

van Oers JM, Wild PJ, Burger M, Denzinger S, Stoehr R, Rosskopf E, Hofstaedter F, Steyerberg EW, Klinkhammer-Schalke M, Zwarthoff EC, van der Kwast TH, Hartmann A. van Oers JM, et al. Among authors: zwarthoff ec. Eur Urol. 2007 Sep;52(3):760-8. doi: 10.1016/j.eururo.2007.01.009. Epub 2007 Jan 12. Eur Urol. 2007. PMID: 17240035

3

Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]).

van der Aa MN, Zwarthoff EC, Steyerberg EW, Boogaard MW, Nijsen Y, van der Keur KA, van Exsel AJ, Kirkels WJ, Bangma C, van der Kwast TH. van der Aa MN, et al. Among authors: zwarthoff ec. Eur Urol. 2009 Mar;55(3):659-67. doi: 10.1016/j.eururo.2008.05.001. Epub 2008 May 15. Eur Urol. 2009. PMID: 18501499

4

Bladder cancer biomarkers and their role in surveillance and screening.

Van Tilborg AA, Bangma CH, Zwarthoff EC. Van Tilborg AA, et al. Among authors: zwarthoff ec. Int J Urol. 2009 Jan;16(1):23-30. doi: 10.1111/j.1442-2042.2008.02174.x. Int J Urol. 2009. PMID: 19120523 Review.

5

Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial.

van der Aa MN, Steyerberg EW, Bangma C, van Rhijn BW, Zwarthoff EC, van der Kwast TH. van der Aa MN, et al. Among authors: zwarthoff ec. J Urol. 2010 Jan;183(1):76-80. doi: 10.1016/j.juro.2009.08.150. J Urol. 2010. PMID: 19913254 Clinical Trial.

6

In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case report.

Zuiverloon TC, Abas CS, van der Keur KA, Vermeij M, Tjin SS, van Tilborg AG, Busstra M, Zwarthoff EC. Zuiverloon TC, et al. Among authors: zwarthoff ec. BMC Urol. 2010 Feb 26;10:5. doi: 10.1186/1471-2490-10-5. BMC Urol. 2010. PMID: 20187926 Free PMC article.

7

Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.

Zuiverloon TC, van der Aa MN, van der Kwast TH, Steyerberg EW, Lingsma HF, Bangma CH, Zwarthoff EC. Zuiverloon TC, et al. Among authors: zwarthoff ec. Clin Cancer Res. 2010 Jun 1;16(11):3011-8. doi: 10.1158/1078-0432.CCR-09-3013. Epub 2010 Apr 19. Clin Cancer Res. 2010. PMID: 20404005

8

Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer.

van Rhijn BW, Zuiverloon TC, Vis AN, Radvanyi F, van Leenders GJ, Ooms BC, Kirkels WJ, Lockwood GA, Boevé ER, Jöbsis AC, Zwarthoff EC, van der Kwast TH. van Rhijn BW, et al. Among authors: zwarthoff ec. Eur Urol. 2010 Sep;58(3):433-41. doi: 10.1016/j.eururo.2010.05.043. Epub 2010 Jun 9. Eur Urol. 2010. PMID: 20646825

9

Optimization of nonmuscle invasive bladder cancer recurrence detection using a urine based FGFR3 mutation assay.

Zuiverloon TC, Tjin SS, Busstra M, Bangma CH, Boevé ER, Zwarthoff EC. Zuiverloon TC, et al. Among authors: zwarthoff ec. J Urol. 2011 Aug;186(2):707-12. doi: 10.1016/j.juro.2011.03.141. Epub 2011 Jun 17. J Urol. 2011. PMID: 21683397

10

A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.

Zuiverloon TC, Beukers W, van der Keur KA, Munoz JR, Bangma CH, Lingsma HF, Eijkemans MJ, Schouten JP, Zwarthoff EC. Zuiverloon TC, et al. Among authors: zwarthoff ec. BJU Int. 2012 Mar;109(6):941-8. doi: 10.1111/j.1464-410X.2011.10428.x. Epub 2011 Jul 14. BJU Int. 2012. PMID: 21756281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page